Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery or Adenoidectomy

NCT02453841 is registered in ClinicalTrials.gov with Richard Cartabuke as lead sponsor.

NCT NCT02453841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02453841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery or Adenoidectomy
Lead sponsor
Richard Cartabuke
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
April 20, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoidectomy, functional endoscopic sinus surgery (fess), turbinate surgery